- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02240147
Start-to-Sport - Home-based Exercise for Adolescents and Adults With Congenital Heart Disease (S2S-ACHD)
January 14, 2019 updated by: Roselien Buys, KU Leuven
Start-to-Sport - Feasibility and Efficacy of Individualized, Telemonitored, Home-based Exercise for Adolescents and Adults With Congenital Heart Disease
Almost 1% of all baby's is born with a heart defect (CHD) and most of them survive.
Even though outcomes are good, they need lifelong follow-up because of a higher risk for cardiovascular diseases.
Studies have shown that patients with CHD are not active enough and that a substantial amount of patients is overweight.
Hence preventive strategies and education should not only focus on the heart problem, but also on a healthy lifestyle including physical activity.
Recently a new guideline introduced exercise prescription based on the absence/presence of certain key elements.
However, a number of important questions remain that preclude implementation in clinical practice.
Therefore a 'Start-to-Sport' program for adults with CHD, based on this new guideline, will be investigated.
This study is a randomized controlled trial that investigates the effects of the program on daily physical activity, exercise capacity, quality of life and exercise self-efficacy both in short (12 weeks) and long (52 weeks) term, along with possible mechanisms for the training effects by using a new exercise-testing protocol that looks simultaneously to all body parts that are involved during exercise.
Ultimately, our findings will result in the implementation of the guideline in clinical practice.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Leuven, Belgium
- University Hospitals Leuven
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 65 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- adolescents and adults with congenital heart disease
- 16 to 65 years
Exclusion Criteria:
- congenital rhythm or conduction disorders
- isolated congenital coronary artery anomalies
- pregnancy
- being listed for heart transplantation
- inability to perform standard physical activities due to mental/physical disability.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control group
|
|
Experimental: home-based exercise training
|
During a 30 minute face-to-face motivational interview with an exercise specialist, the patient will be advised and coached about his exercise prescription, on how to implement it in his own daily life and on how to prevent relapse.
Furthermore, the patients will receive instructions on how to monitor their exercise intensity and on recognizing adverse signals.
During the following 12 weeks, patients will be asked to exercise 4.5 hours per week within the prescribed exercise intensity range according to the guidelines.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
peak oxygen uptake
Time Frame: baseline, post-intervention, after 1 year
|
baseline, post-intervention, after 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
physical activity
Time Frame: baseline, post-intervention and after 1 year
|
Physical activity will be assessed by means of the Sensewear mini armband.
The patient will be asked to wear the device day and night during 1 week, while also taking notes of the physical activities undertaken by means of a logbook.
|
baseline, post-intervention and after 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Roselien Buys, PhD, KU Leuven
- Principal Investigator: Werner Budts, PhD, KU Leuven
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2015
Primary Completion (Actual)
September 30, 2018
Study Completion (Actual)
September 30, 2018
Study Registration Dates
First Submitted
September 11, 2014
First Submitted That Met QC Criteria
September 11, 2014
First Posted (Estimate)
September 15, 2014
Study Record Updates
Last Update Posted (Actual)
January 15, 2019
Last Update Submitted That Met QC Criteria
January 14, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- S2S-ACHD
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Congenital Heart Defect
-
Asklepion Pharmaceuticals, LLCCompletedAtrial Septal Defect | Atrioventricular Septal Defect | Ventricular Septal DefectUnited States
-
Occlutech International ABRecruitingMuscular Ventricular Septal DefectTurkey
-
Ayman khairy MohamedCompletedAtrial Septal Defect, Secundum TypeEgypt
-
Abbott Medical DevicesTerminatedAtrial Septal Defect SecundumUnited States
-
Assiut UniversityWithdrawnASD2(Secundum Atrial Septal Defect)
-
GLYCAR SA (Pty) LtdRecruitingCardiac Anomaly | Cardiac Defect | Pericardial DefectSouth Africa
-
Chinese Academy of Medical Sciences, Fuwai HospitalUnknownPerimembranous Ventricular Septal DefectChina
-
Occlutech International ABActive, not recruitingPerimembranous Ventricular Septal DefectThailand, Germany, Ireland, Vietnam
-
Lund University HospitalGöteborg University; Region Jönköping CountyActive, not recruitingCardiovascular Diseases | Atrial Septal Defect | Patent Ductus Arteriosus | Ventricular Septal Defect | Aortopulmonary Window | Heart Disease Congenital | Partial Anomalous Pulmonary Venous ConnectionSweden
-
Nobles Medical Technologies II IncEnrolling by invitationForamen Ovale, Patent | Septal Defect, Atrial | Septal Defect, HeartUnited States, Italy
Clinical Trials on home-based exercise training
-
McMaster UniversityHamilton Health Sciences Corporation; Heart and Stroke Foundation of OntarioCompletedCongestive Heart FailureCanada
-
Paracelsus Medical UniversityLudwig Boltzmann Institute for Digital Health and PreventionCompleted
-
Cardenal Herrera UniversityHospital de ManisesCompletedEnd Stage Renal Disease on DialysisSpain, Belgium, Greece, Sweden
-
Chang Gung Memorial HospitalCompletedModerate to Severe COPD Receiving Home Exercise TrainingTaiwan
-
Hospital de Clinicas de Porto AlegreRecruitingBreast Cancer | Prostate CancerBrazil
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São Paulo; Hospital das Clínicas...UnknownCovid19 | Corona Virus Infection | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)Brazil
-
Maxima Medical CenterCompletedMyocardial Infarction | Acute Coronary SyndromeNetherlands
-
Bezmialem Vakif UniversityCompletedAdolescent Idiopathic ScoliosisTurkey
-
Instituto Politécnico de LeiriaCompletedLung NeoplasmPortugal
-
University of AlbertaCompleted